The experiment 'Dosimetric Mapping' conducted as part of the science program of NASA's Human Research Facility (HRF) between March and August 2001 was designed to measure integrated total absorbed doses (ionising radiation and neutrons), heavy ion fluxes and its energy, mass and linear energy transfer (LET) spectra, time-dependent count rates of charged particles and their corresponding dose rates at different locations inside the US Lab at the International Space Station. Owing to the variety of particles and energies, a dosimetry package consisting of thermoluminescence dosemeter (TLD) chips and nuclear track detectors with and without converters (NTDPs), a silicon dosimetry telescope (DOSTEL), four mobile silicon detector units (MDUs) and a TLD reader unit (PILLE) with 12 TLD bulbs as dosemeters was used. Dose rates of the ionising part of the radiation field measured with TLD bulbs applying the PILLE readout system at different locations varied between 153 and 231 microGy d(-1). The dose rate received by the active devices fits excellent to the TLD measurements and is significantly lower compared with measurements for the Shuttle (STS) to MIR missions. The comparison of the absorbed doses from passive and active devices showed an agreement within +/- 10%. The DOSTEL measurements in the HRF location yielded a mean dose equivalent rate of 535 microSv d(-1). DOSTEL measurements were also obtained during the Solar Particle Event on 15 April 2001.
Space radiation hazards are recognized as a key concern for human space flight. For long-term interplanetary missions, they constitute a potentially limiting factor since current protection limits for low-Earth orbit missions may be approached or even exceeded. In such a situation, an accurate risk assessment requires knowledge of equivalent doses in critical radiosensitive organs rather than only skin doses or ambient doses from area monitoring. To achieve this, the MATROSHKA experiment uses a human phantom torso equipped with dedicated detector systems. We measured for the first time the doses from the diverse components of ionizing space radiation at the surface and at different locations inside the phantom positioned outside the International Space Station, thereby simulating an extravehicular activity of an astronaut. The relationships between the skin and organ absorbed doses obtained in such an exposure show a steep gradient between the doses in the uppermost layer of the skin and the deep organs with a ratio close to 20. This decrease due to the body self-shielding and a concomitant increase of the radiation quality factor by 1.7 highlight the complexities of an adequate dosimetry of space radiation. The depth-dose distributions established by MATROSHKA serve as benchmarks for space radiation models and radiation transport calculations that are needed for mission planning.
The Mobile Radiation Exposure Control System's (Liulin-4 type) main purpose is to monitor simultaneously the doses and fluxes at 4 independent places. It can also be used for personnel dosimetry. The system consists of 4 battery-operated 256-channel dosimeters-spectrometers. We describe results obtained during the calibrations of the spectrometers at the Cyclotron facilities of the University of Louvain, Belgium and of the National Institute of Radiological Sciences-STA, Chiba, Japan with protons of energies up to 70 MeV. The angular sensitivities of the devices are studied and compared with MonteCarlo predictions. We also present the results obtained at the HIMAC accelerator with 500 MeV/u Fe ions and at the CERN high energy radiation reference fields. Records made during airplane flights are shown and compared with the predictions of the CARI-6 model.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.